| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
membrane metalloendopeptidase like 1 | 0.606 | 0.692 | 1.2E-22 |
|
disease | 0.440 | None | 0.909 | 3 | 2 | 2008 | 2019 | ||||||||
|
cyclin dependent kinase 6 | 0.471 | 0.731 | 0.98 |
|
disease | 0.440 | None | 0.714 | 1 | 1 | 2008 | 2019 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.430 | None | 1.000 | 2 | 2 | 2005 | 2019 | ||||||||
|
NFKB inhibitor epsilon | 0.700 | 0.385 | 0.77 |
|
disease | 0.420 | None | 1.000 | 2 | 2 | 2012 | 2016 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
disease | 0.410 | None | 1.000 | 3 | 3 | 2012 | 2019 | ||||||||
|
kinesin family member 5A | 0.593 | 0.731 | 1.00 |
|
disease | 0.410 | None | 1.000 | 2 | 1 | 2008 | 2014 | ||||||||
|
phospholipase D family member 4 | 0.780 | 0.500 | 7.7E-13 |
|
disease | 0.410 | None | 1.000 | 1 | 2 | 2012 | 2018 | ||||||||
|
deoxyribonuclease 1 like 3 | 0.575 | 0.769 | 3.0E-05 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
sprouty related EVH1 domain containing 2 | 0.711 | 0.577 | 2.9E-07 |
|
disease | 0.400 | None | 1.000 | 5 | 4 | 2010 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.400 | None | 1.000 | 3 | 15 | 2007 | 2011 | ||||||||
|
RAS guanyl releasing protein 1 | 0.572 | 0.731 | 0.97 |
|
disease | 0.400 | None | 1.000 | 2 | 2 | 2012 | 2019 | ||||||||
|
regulator of calcineurin 1 | 0.572 | 0.808 | 1.7E-02 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
annexin A3 | 0.610 | 0.615 | 6.5E-12 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 0.962 | 4 | 7 | 1990 | 2016 | ||||||||
|
transporter 2, ATP binding cassette subfamily B member | 0.517 | 0.808 | 6.9E-11 |
|
disease | 0.200 | None | 1.000 | 3 | 4 | 1994 | 2016 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.200 | None | 1.000 | 3 | 4 | 1997 | 2017 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 1.000 | 3 | 43 | 1982 | 2018 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 1.000 | 2 | 2 | 1981 | 2014 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.200 | None | 0.944 | 1 | 14 | 1993 | 2019 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1992 | 2018 | ||||||||
|
CD226 molecule | 0.548 | 0.769 | 3.9E-02 |
|
disease | 0.200 | None | 0.909 | 1 | 1 | 2009 | 2018 | ||||||||
|
autoimmune regulator | 0.516 | 0.808 | 4.0E-12 |
|
disease | 0.190 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
dipeptidyl peptidase 4 | 0.420 | 0.808 | 7.3E-09 |
|
disease | 0.190 | None | 0.900 | 1 | 1 | 2014 | 2019 | ||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
disease | 0.180 | None | 1.000 | 3 | 6 | 2001 | 2019 | ||||||||
|
major histocompatibility complex, class II, DM beta | 0.638 | 0.615 | 2.5E-03 |
|
disease | 0.180 | None | 0.800 | 2 | 5 | 1997 | 2009 |